147 related articles for article (PubMed ID: 14739005)
1. Haloperidol versus risperidone on rat "early onset" vacuous chewing.
Marchese G; Bartholini F; Casu MA; Ruiu S; Casti P; Congeddu E; Tambaro S; Pani L
Behav Brain Res; 2004 Feb; 149(1):9-16. PubMed ID: 14739005
[TBL] [Abstract][Full Text] [Related]
2. Sub-chronic treatment with classical but not atypical antipsychotics produces morphological changes in rat nigro-striatal dopaminergic neurons directly related to "early onset" vacuous chewing.
Marchese G; Casu MA; Bartholini F; Ruiu S; Saba P; Gessa GL; Pani L
Eur J Neurosci; 2002 Apr; 15(7):1187-96. PubMed ID: 11982629
[TBL] [Abstract][Full Text] [Related]
3. The relationship between dopamine D2 receptor occupancy and the vacuous chewing movement syndrome in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Psychopharmacology (Berl); 2003 Jan; 165(2):166-71. PubMed ID: 12417967
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate.
Egan MF; Ferguson JN; Hyde TM
Brain Res Bull; 1995; 38(4):355-63. PubMed ID: 8535858
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.
Egan MF; Hurd Y; Ferguson J; Bachus SE; Hamid EH; Hyde TM
Psychopharmacology (Berl); 1996 Oct; 127(4):337-45. PubMed ID: 8923569
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains.
Tamminga CA; Dale JM; Goodman L; Kaneda H; Kaneda N
Psychopharmacology (Berl); 1990; 102(4):474-8. PubMed ID: 1982902
[TBL] [Abstract][Full Text] [Related]
7. Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide.
Naidu PS; Kulkarni SK
Behav Pharmacol; 2001 Jun; 12(3):209-16. PubMed ID: 11485057
[TBL] [Abstract][Full Text] [Related]
8. Relationship of orofacial movements to behavioural repertoire as assessed topographically over the course of 6-month haloperidol treatment followed by 4-month withdrawal.
De Souza IE; Dawson NM; Clifford JJ; Waddington JL; Meredith GE
Psychopharmacology (Berl); 2003 Aug; 169(1):28-34. PubMed ID: 12830366
[TBL] [Abstract][Full Text] [Related]
9. Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate.
Hyde TM; Egan MF; Wing LL; Wyatt RJ; Weinberger DR; Kleinman JE
Psychopharmacology (Berl); 1995 Mar; 118(2):142-9. PubMed ID: 7617800
[TBL] [Abstract][Full Text] [Related]
10. Electron spin resonance spectroscopy reveals alpha-phenyl-N-tert-butylnitrone spin-traps free radicals in rat striatum and prevents haloperidol-induced vacuous chewing movements in the rat model of human tardive dyskinesia.
Rogoza RM; Fairfax DF; Henry P; N-Marandi S; Khan RF; Gupta SK; Mishra RK
Synapse; 2004 Dec; 54(3):156-63. PubMed ID: 15452862
[TBL] [Abstract][Full Text] [Related]
11. Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats.
Haleem DJ; Samad N; Haleem MA
Pharmacol Biochem Behav; 2007 May; 87(1):115-21. PubMed ID: 17498786
[TBL] [Abstract][Full Text] [Related]
12. Effects of clozapine and haloperidol on baseline levels of vacuous jaw movements in aged rats.
Steinpreis RE; Parret F; Summ RM; Panos JJ
Behav Brain Res; 1997 Jul; 86(2):165-9. PubMed ID: 9134151
[TBL] [Abstract][Full Text] [Related]
13. Enhanced 5-HT2C receptor signaling is associated with haloperidol-induced "early onset" vacuous chewing in rats: implications for antipsychotic drug therapy.
Wolf WA; Bieganski GJ; Guillen V; Mignon L
Psychopharmacology (Berl); 2005 Oct; 182(1):84-94. PubMed ID: 15986194
[TBL] [Abstract][Full Text] [Related]
14. Multidose risperidone treatment evaluated in a rodent model of tardive dyskinesia.
Gao XM; Cooper T; Suckow RF; Tamminga CA
Neuropsychopharmacology; 2006 Sep; 31(9):1864-8. PubMed ID: 16319911
[TBL] [Abstract][Full Text] [Related]
15. Extract of Ginkgo biloba is equivalent to vitamin E in attenuating and preventing vacuous chewing movements in a rat model of tardive dyskinesia.
An HM; Tan YL; Shi J; Wang ZR; Li J; Wang YC; Kosten TR; Zhou DF; Yang FD; Zhang XY
Behav Pharmacol; 2013 Oct; 24(7):610-6. PubMed ID: 23994817
[TBL] [Abstract][Full Text] [Related]
16. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
[TBL] [Abstract][Full Text] [Related]
17. The effects of raclopride on vacuous jaw movements in rats following acute administration.
Steinpreis RE; Kaczmarek HJ; Harrington A
Physiol Behav; 1996 Jul; 60(1):253-6. PubMed ID: 8804672
[TBL] [Abstract][Full Text] [Related]
18. Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements.
Egan MF; Ferguson J; Hyde TM
Pharmacol Biochem Behav; 1996 Feb; 53(2):401-10. PubMed ID: 8808150
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of within-day continuous vs. transient dopamine D2 receptor occupancy in the development of vacuous chewing movements (VCMs) in rats.
Turrone P; Remington G; Kapur S; Nobrega JN
Neuropsychopharmacology; 2003 Aug; 28(8):1433-9. PubMed ID: 12838271
[TBL] [Abstract][Full Text] [Related]
20. Alteration of Cytokines Levels in the Striatum of Rats: Possible Participation in Vacuous Chewing Movements Induced by Antipsycotics.
Peroza LR; Schaffer LF; De Freitas CM; Leal CQ; Ferrari MC; Duarte MM; Fachinetto R
Neurochem Res; 2016 Sep; 41(9):2481-9. PubMed ID: 27230882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
